Global ENT Devices Market 2017-2021
About ENT Devices
Ear, nose and throat (ENT) devices signify devices used in the diagnosis or treatment procedures related to ear, nose and throat disorders/disabilities. These products include diagnostic, therapeutic and surgical devices used for rectifying problems associated with hearing, speaking, and smelling. Based on products, ENT devices are segmented into — diagnostics devices, surgical devices, hearing implants, voice prostheses and nasal implants.Technavio’s analysts forecast the global ENT devices market to grow at a CAGR of 4.67% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global ENT devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of ENT devices.The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global ENT Devices Market 2017-2021
Technavio recognizes the following companies as the key players in the global ENT devices market: Medtronic, Cochlear, OLYMPUS, Smith & Nephew, and Siemens Healthineers.
Other Prominent Vendors in the market are: Acclarent (subsidiary of Johnson and Johnson), Atos Medical, Avada Audiology & Hearing Care, Bernafon, Beltone, GN ReSound, HOYA, KARL STORZ, Miracle-Ear, Rexton, Sonova Holding, Stryker, Starkey Hearing Technologies, Sonic Innovations, Widex, and William Demant Holding.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is technological advances. ENT devices have become much more technologically advanced than ever before and its continuously advancing. Advances in radiologic imaging have potentially increased the practitioner's diagnostic and therapeutic capabilities in ENT surgery. This is mainly in two particular areas: in-office CT scanning or point-of-care CT (POC-CT), and intraoperative CT scanning (IO-CT).”
According to the report, one driver in the market is growing geriatric population. Every nation in the world is encountering an increase in the number and proportion of older people in their populace. Aging population has become one of the most significant social transformations of the modern century with implications for nearly all sectors of society, including labor and financial markets, the demand for goods and services such as housing, social protection, and transportation as well as family structures and intergenerational ties.
Further, the report states that one challenge in the market is social stigma and lack of awareness. Individuals with hearing loss need to manage adopting their life with hearing devices. In fact, individuals hold up for a normal of seven years before getting hearing devices after noticing their hearing loss. According to the Journal of Medical Professionals with Hearing Losses, people consider deaf and hard of hearing individual with a mixture of fear, disrespect, dislike, misunderstanding, and pity. Many had this misconception that individuals with hearing loss did not have the capacity to be educated, and it remained until mid-1700s when people began considering that youth with hearing loss could in fact learn.
Medtronic, Cochlear, OLYMPUS, Smith & Nephew, Siemens Healthineers, Acclarent (subsidiary of Johnson and Johnson), Atos Medical, Avada Audiology & Hearing Care, Bernafon, Beltone, GN ReSound, HOYA, KARL STORZ, Miracle-Ear, Rexton, Sonova Holding, Stryker, Starkey Hearing Technologies, Sonic Innovations, Widex, and William Demant Holding.